Tohoku University
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1907-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.tohoku.ac.jp
Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation
- Conditions
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2014-05-26
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 7000
- Registration Number
- NCT02147444
- Locations
- 🇯🇵
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Amnesia After Surgery for Anterior Communicating Aneurysm： High Resolution Magnetic Resonance (MR) Imaging Findings
Completed
- Conditions
- First Posted Date
- 2013-08-09
- Last Posted Date
- 2013-08-09
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 14
- Registration Number
- NCT01919775
Pharmacokinetic Study on N-acetylneuraminic Acid
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 6
- Registration Number
- NCT01236898
- Locations
- 🇯🇵
Tohoku University Hospital, Sendai, Miyagi, Japan
Vitamin D Supplementation Prevents Elderly Pneumonia
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2009-04-08
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 100
- Registration Number
- NCT00877422
- Locations
- 🇯🇵
Institute of Development, Aging and Cancer, Tohoku University, 1-1,Seiryo-machi,Aoba-ku,Sendai, Japan
Effect of Bifidobacterium on Irritable Bowel Syndrome
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2008-08-20
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 50
- Registration Number
- NCT00737841
- Locations
- 🇯🇵
Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
Prognosis of Atypical Pituitary Adenomas
- Conditions
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2007-05-15
- Lead Sponsor
- Tohoku University
- Registration Number
- NCT00473369
Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan
- First Posted Date
- 2006-12-29
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 1145
- Registration Number
- NCT00417222
- Locations
- 🇯🇵
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai-city, Japan
Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 75
- Registration Number
- NCT00107393
- Locations
- 🇯🇵
Hokkaido Cancer Center, Hokkaido, Japan
🇯🇵Hiroshima University Hospital, Hiroshima, Japan
🇯🇵Saint Marianna University School of Medicine, Kanagawa, Japan
© Copyright 2024. All Rights Reserved by MedPath